65,437 trials
Healthy
Primary: Maximum Plasma Morphine Concentration — 37.5; 38.0 ng/mL — p=<0.05
Healthy
Primary: Mean Maximum Plasma Morphine Concentration — 37.3; 32.8 ng/mL
Healthy
Primary: Maximum Plasma Morphine Concentration — 42.8; 46.8 ng/mL
Healthy
Primary: Maximum Plasma Morphine Concentration — 4.60; 4.29 ng/mL
Healthy
Primary: Maximum Plasma Morphine Concentration — 5.23; 4.15 ng/mL
Hypertension
Primary: Change in SBP (Systolic Blood Pressure) — -18 mmHg — p=<0.0001
Breast Cancer
Primary: Best Overall Response — 1; 0; 1; 12 participants
Esophagitis, Reflux · Esophagitis, Peptic
Primary: Percentage of Subjects Who Maintained Complete Healing of Erosive Esophagitis as Assessed by Endoscopy - Crude Rate Analysis. — 14.3; 66.4; 66.4 Percentage of Subjects…
Tightening of Skin Laxity
Primary: Serious Adverse Events — 0 Number of Serious Adverse Events
Esophagitis, Reflux · Esophagitis, Peptic
Primary: Percentage of Subjects Who Maintained Complete Healing of Erosive Esophagitis as Assessed by Endoscopy - Crude Rate Analysis. — 14.3; 66.4; 64.5 Percentage of Subjects…
Diabetes Mellitus, Type 2
Primary: Change in ASIiAUC During a Hyperglycemic Clamp Test. — 643.40; 686.41; 786.12; 747.26 uIU-min/ml — p=0.282
Esophagitis, Reflux · Esophagitis, Peptic
Primary: Percentage of Subjects Who Maintained Complete Healing of Erosive Esophagitis as Assessed by Endoscopy - Crude Rate Analysis. — 14.3; 66.4; 64.5 Percentage of Subjects…
Influenza
Primary: Percentage of Participants With Solicited Local and Systemic Reactions After Fluzone® Vaccination — 60; 23; 8; 5 Percentage of Participants
Gingival Diseases
Primary: Plaque Index — 2.45; 2.22; 2.54; 2.56 Units on a scale — p=0.05
Influenza
Primary: Number of Participants Who Had Solicited Injection Site and Systemic Reactions After Vaccination With Fluzone 2007-2008 Formulation — 13; 4; 9; 2 Participants